BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25078453)

  • 1. Performance of cryptococcal antigen lateral flow assay using saliva in Ugandans with CD4 <100.
    Kwizera R; Nguna J; Kiragga A; Nakavuma J; Rajasingham R; Boulware DR; Meya DB
    PLoS One; 2014; 9(7):e103156. PubMed ID: 25078453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY.
    Vidal JE; Boulware DR
    Rev Inst Med Trop Sao Paulo; 2015 Sep; 57 Suppl 19(Suppl 19):38-45. PubMed ID: 26465368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of cryptococcal antigen lateral flow assay in serum, cerebrospinal fluid, whole blood, and urine in HIV-infected patients with culture-proven cryptococcal meningitis admitted at a Brazilian referral center.
    Vidal JE; Toniolo C; Paulino A; Colombo AL; Martins MDA; Meira CDS; Azevedo RGS; Pereira-Chioccola VL; Gomes HR; Lazera MDS; Oliveira ACP; Boulware DR
    Rev Inst Med Trop Sao Paulo; 2018; 60():e1. PubMed ID: 29451598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Dynamiker Cryptococcal Antigen Lateral Flow Assay for the Diagnosis of HIV-Associated Cryptococcosis.
    Kwizera R; Omali D; Tadeo K; Kasibante J; Rutakingirwa MK; Kagimu E; Ssebambulidde K; Williams DA; Rhein J; Boulware D; Meya DB
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33268538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast.
    Boulware DR; Rolfes MA; Rajasingham R; von Hohenberg M; Qin Z; Taseera K; Schutz C; Kwizera R; Butler EK; Meintjes G; Muzoora C; Bischof JC; Meya DB
    Emerg Infect Dis; 2014 Jan; 20(1):45-53. PubMed ID: 24378231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
    Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
    Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
    Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
    Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease.
    Boyd K; Kouamou V; Hlupeni A; Tangwena Z; Ndhlovu CE; Makadzange AT;
    Microbiol Spectr; 2022 Aug; 10(4):e0107522. PubMed ID: 35924841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of clinic-based cryptococcal antigen lateral flow assay screening in HIV-infected adults in South Africa.
    Drain PK; Hong T; Krows M; Govere S; Thulare H; Wallis CL; Gosnell BI; Moosa MY; Bassett IV; Celum C
    Sci Rep; 2019 Feb; 9(1):2687. PubMed ID: 30804356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study.
    Williams DA; Kiiza T; Kwizera R; Kiggundu R; Velamakanni S; Meya DB; Rhein J; Boulware DR
    Clin Infect Dis; 2015 Aug; 61(3):464-7. PubMed ID: 25838287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients.
    Wake RM; Britz E; Sriruttan C; Rukasha I; Omar T; Spencer DC; Nel JS; Mashamaite S; Adelekan A; Chiller TM; Jarvis JN; Harrison TS; Govender NP
    Clin Infect Dis; 2018 Feb; 66(5):686-692. PubMed ID: 29028998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory Reflex and Clinic-Based Point-of-Care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality Among People Living With HIV.
    Drain PK; Galagan SR; Govere S; Krows M; Thulare H; Wallis CL; Gosnell BI; Moosa MY; Celum C; Bassett IV
    J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1205-1213. PubMed ID: 33990495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Serum Cryptococcal Antigen Testing Using Two Novel Semiquantitative Lateral Flow Assays in Persons with Cryptococcal Antigenemia.
    Skipper C; Tadeo K; Martyn E; Nalintya E; Rajasingham R; Meya DB; Kafufu B; Rhein J; Boulware DR
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 32024729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
    Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
    PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal Meningitis.
    Tadeo KK; Nimwesiga A; Kwizera R; Apeduno L; Martyn E; Okirwoth M; Nalintya E; Rajasingham R; Williams DA; Rhein J; Meya DB; Kafufu B; Boulware DR; Skipper CP
    J Clin Microbiol; 2021 Jul; 59(8):e0086021. PubMed ID: 34076472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.
    Mamuye AT; Bornstein E; Temesgen O; Blumberg HM; Kempker RR
    Am J Trop Med Hyg; 2016 Oct; 95(4):786-792. PubMed ID: 27527636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients.
    Kwizera R; Akampurira A; Williams D; Boulware DR; Meya DB;
    PLoS One; 2017; 12(7):e0182108. PubMed ID: 28750078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: Point of Care Cryptococcal Antigen Screening: Pipetting Finger-Prick Blood Improves Performance of Immunomycologics Lateral Flow Assay.
    Wake RM; Jarvis JN; Harrison TS; Govender NP
    J Acquir Immune Defic Syndr; 2018 Aug; 78(5):574-578. PubMed ID: 29771787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda.
    Nalintya E; Meya DB; Lofgren S; Huppler Hullsiek K; Boulware DR; Rajasingham R
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):231-238. PubMed ID: 29509588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease.
    Tenforde MW; Boyer-Chammard T; Muthoga C; Tawe L; Milton T; Rulaganyang I; Lechiile K; Rukasha I; Leeme TB; Govender NP; Ngidi J; Mine M; Molloy SF; Harrison TS; Lortholary O; Jarvis JN
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.